Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

NHERF1 Is Required for Localization of PMCA2 and Suppression of Early Involution in the Female Lactating Mammary Gland.

Jeong J, Kim W, Hens J, Dann P, Schedin P, Friedman PA, Wysolmerski JJ.

Endocrinology. 2019 Aug 1;160(8):1797-1810. doi: 10.1210/en.2019-00230.

PMID:
31087002
2.

Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk.

Goddard ET, Bassale S, Schedin T, Jindal S, Johnston J, Cabral E, Latour E, Lyons TR, Mori M, Schedin PJ, Borges VF.

JAMA Netw Open. 2019 Jan 4;2(1):e186997. doi: 10.1001/jamanetworkopen.2018.6997.

3.

A METHOD FOR QUANTIFICATION OF CALPONIN EXPRESSION IN MYOEPITHELIAL CELLS IN IMMUNOHISTOCHEMICAL IMAGES OF DUCTAL CARCINOMA IN SITU.

Gray E, Mitchell E, Jindal S, Schedin P, Chang YH.

Proc IEEE Int Symp Biomed Imaging. 2018 Apr;2018:796-799. doi: 10.1109/ISBI.2018.8363692. Epub 2018 May 24.

4.

Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer.

Pennock ND, Martinson HA, Guo Q, Betts CB, Jindal S, Tsujikawa T, Coussens LM, Borges VF, Schedin P.

J Immunother Cancer. 2018 Oct 1;6(1):98. doi: 10.1186/s40425-018-0406-y.

5.

Semaphorin 7A Promotes Macrophage-Mediated Lymphatic Remodeling during Postpartum Mammary Gland Involution and in Breast Cancer.

Elder AM, Tamburini BAJ, Crump LS, Black SA, Wessells VM, Schedin PJ, Borges VF, Lyons TR.

Cancer Res. 2018 Nov 15;78(22):6473-6485. doi: 10.1158/0008-5472.CAN-18-1642. Epub 2018 Sep 25.

PMID:
30254150
6.

Erratum to: RNA-Seq and Expression Arrays: Selection Guidelines for Genome-Wide Expression Profiling.

Minnier J, Pennock ND, Guo Q, Schedin P, Harrington CA.

Methods Mol Biol. 2018;1783:E1. doi: 10.1007/978-1-4939-7834-2_19.

PMID:
29992527
7.

Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer.

Giles ED, Jindal S, Wellberg EA, Schedin T, Anderson SM, Thor AD, Edwards DP, MacLean PS, Schedin P.

Breast Cancer Res. 2018 Jun 14;20(1):50. doi: 10.1186/s13058-018-0974-2.

8.

Mucosal Immunity in the Female Murine Mammary Gland.

Betts CB, Pennock ND, Caruso BP, Ruffell B, Borges VF, Schedin P.

J Immunol. 2018 Jul 15;201(2):734-746. doi: 10.4049/jimmunol.1800023. Epub 2018 Jun 8.

9.

RNA-Seq and Expression Arrays: Selection Guidelines for Genome-Wide Expression Profiling.

Minnier J, Pennock ND, Guo Q, Schedin P, Harrington CA.

Methods Mol Biol. 2018;1783:7-33. doi: 10.1007/978-1-4939-7834-2_2. Erratum in: Methods Mol Biol. 2018;1783:E1. Guo, Quichen [corrected to Guo, Qiuchen].

PMID:
29767356
10.

The Androgen Receptor Supports Tumor Progression After the Loss of Ovarian Function in a Preclinical Model of Obesity and Breast Cancer.

Wellberg EA, Checkley LA, Giles ED, Johnson SJ, Oljira R, Wahdan-Alaswad R, Foright RM, Dooley G, Edgerton SM, Jindal S, Johnson GC, Richer JK, Kabos P, Thor AD, Schedin P, MacLean PS, Anderson SM.

Horm Cancer. 2017 Dec;8(5-6):269-285. doi: 10.1007/s12672-017-0302-9. Epub 2017 Jul 24.

11.

IFPA meeting 2016 workshop report III: Decidua-trophoblast interactions; trophoblast implantation and invasion; immunology at the maternal-fetal interface; placental inflammation.

Aplin JD, Beristain A, DaSilva-Arnold S, Dunk C, Duzyj C, Golos TG, Kemmerling U, Knöfler M, Mitchell MD, Olson DM, Petroff M, Pollheimer J, Reyes L, Schedin P, Soares MJ, Stencel-Baerenwald J, Thornburg KL, Lash GE.

Placenta. 2017 Dec;60 Suppl 1:S15-S19. doi: 10.1016/j.placenta.2017.04.019. Epub 2017 Apr 25. Review.

PMID:
28456431
12.

Physiologically activated mammary fibroblasts promote postpartum mammary cancer.

Guo Q, Minnier J, Burchard J, Chiotti K, Spellman P, Schedin P.

JCI Insight. 2017 Mar 23;2(6):e89206. doi: 10.1172/jci.insight.89206.

13.

Metformin Accumulation Correlates with Organic Cation Transporter 2 Protein Expression and Predicts Mammary Tumor Regression In Vivo.

Checkley LA, Rudolph MC, Wellberg EA, Giles ED, Wahdan-Alaswad RS, Houck JA, Edgerton SM, Thor AD, Schedin P, Anderson SM, MacLean PS.

Cancer Prev Res (Phila). 2017 Mar;10(3):198-207. doi: 10.1158/1940-6207.CAPR-16-0211-T. Epub 2017 Feb 2.

14.

Mammary Gland Involution Provides a Unique Model to Study the TGF-β Cancer Paradox.

Guo Q, Betts C, Pennock N, Mitchell E, Schedin P.

J Clin Med. 2017 Jan 13;6(1). pii: E10. doi: 10.3390/jcm6010010. Review.

15.

Mammary extracellular matrix directs differentiation of testicular and embryonic stem cells to form functional mammary glands in vivo.

Bruno RD, Fleming JM, George AL, Boulanger CA, Schedin P, Smith GH.

Sci Rep. 2017 Jan 10;7:40196. doi: 10.1038/srep40196.

16.

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer.

Goddard ET, Fischer J, Schedin P.

J Vis Exp. 2016 Dec 26;(118). doi: 10.3791/54903.

17.

The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis.

Goddard ET, Hill RC, Nemkov T, D'Alessandro A, Hansen KC, Maller O, Mongoue-Tchokote S, Mori M, Partridge AH, Borges VF, Schedin P.

Cancer Discov. 2017 Feb;7(2):177-187. doi: 10.1158/2159-8290.CD-16-0822. Epub 2016 Dec 14.

18.

Quantitative extracellular matrix proteomics to study mammary and liver tissue microenvironments.

Goddard ET, Hill RC, Barrett A, Betts C, Guo Q, Maller O, Borges VF, Hansen KC, Schedin P.

Int J Biochem Cell Biol. 2016 Dec;81(Pt A):223-232. doi: 10.1016/j.biocel.2016.10.014. Epub 2016 Oct 24.

19.

Myoepithelial cells in lobular carcinoma in situ: distribution and immunophenotype.

Wang Y, Jindal S, Martel M, Wu Y, Schedin P, Troxell M.

Hum Pathol. 2016 Sep;55:126-34. doi: 10.1016/j.humpath.2016.05.003. Epub 2016 May 16.

PMID:
27195907
20.

COX-2 modulates mammary tumor progression in response to collagen density.

Esbona K, Inman D, Saha S, Jeffery J, Schedin P, Wilke L, Keely P.

Breast Cancer Res. 2016 Mar 22;18(1):35. doi: 10.1186/s13058-016-0695-3.

21.

Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.

Ruszczyk M, Zirpoli G, Kumar S, Bandera EV, Bovbjerg DH, Jandorf L, Khoury T, Hwang H, Ciupak G, Pawlish K, Schedin P, Masso-Welch P, Ambrosone CB, Hong CC.

Cancer Causes Control. 2016 Feb;27(2):183-98. doi: 10.1007/s10552-015-0696-z. Epub 2015 Nov 30.

22.

Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.

Russell TD, Jindal S, Agunbiade S, Gao D, Troxell M, Borges VF, Schedin P.

Am J Pathol. 2015 Nov;185(11):3076-89. doi: 10.1016/j.ajpath.2015.07.004. Epub 2015 Sep 4.

23.

Mammary epithelial cell phagocytosis downstream of TGF-β3 is characterized by adherens junction reorganization.

Fornetti J, Flanders KC, Henson PM, Tan AC, Borges VF, Schedin P.

Cell Death Differ. 2016 Feb;23(2):185-96. doi: 10.1038/cdd.2015.82. Epub 2015 Jun 26.

24.

Important Role of Menarche in Development of Estrogen Receptor-Negative Breast Cancer in African American Women.

Ambrosone CB, Zirpoli G, Hong CC, Yao S, Troester MA, Bandera EV, Schedin P, Bethea TN, Borges V, Park SY, Chandra D, Rosenberg L, Kolonel LN, Olshan AF, Palmer JR.

J Natl Cancer Inst. 2015 Jun 17;107(9). pii: djv172. doi: 10.1093/jnci/djv172. Print 2015 Sep.

25.

Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women.

Collins LC, Gelber S, Marotti JD, White S, Ruddy K, Brachtel EF, Schapira L, Come SE, Borges VF, Schedin P, Warner E, Wensley T, Tamimi RM, Winer EP, Partridge AH.

Oncologist. 2015 Jul;20(7):713-8. doi: 10.1634/theoncologist.2014-0412. Epub 2015 May 29.

26.

XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer.

Morton JJ, Bird G, Keysar SB, Astling DP, Lyons TR, Anderson RT, Glogowska MJ, Estes P, Eagles JR, Le PN, Gan G, McGettigan B, Fernandez P, Padilla-Just N, Varella-Garcia M, Song JI, Bowles DW, Schedin P, Tan AC, Roop DR, Wang XJ, Refaeli Y, Jimeno A.

Oncogene. 2016 Jan 21;35(3):290-300. doi: 10.1038/onc.2015.94. Epub 2015 Apr 20.

27.

A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium.

Bethea TN, Rosenberg L, Hong CC, Troester MA, Lunetta KL, Bandera EV, Schedin P, Kolonel LN, Olshan AF, Ambrosone CB, Palmer JR.

Breast Cancer Res. 2015 Feb 21;17:22. doi: 10.1186/s13058-015-0535-x.

28.

Tumor mechanics and metabolic dysfunction.

Tung JC, Barnes JM, Desai SR, Sistrunk C, Conklin MW, Schedin P, Eliceiri KW, Keely PJ, Seewaldt VL, Weaver VM.

Free Radic Biol Med. 2015 Feb;79:269-80. doi: 10.1016/j.freeradbiomed.2014.11.020. Epub 2014 Dec 19. Review.

29.

Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium.

Palmer JR, Viscidi E, Troester MA, Hong CC, Schedin P, Bethea TN, Bandera EV, Borges V, McKinnon C, Haiman CA, Lunetta K, Kolonel LN, Rosenberg L, Olshan AF, Ambrosone CB.

J Natl Cancer Inst. 2014 Sep 15;106(10). pii: dju237. doi: 10.1093/jnci/dju237. Print 2014 Oct.

30.

Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression.

Martinson HA, Jindal S, Durand-Rougely C, Borges VF, Schedin P.

Int J Cancer. 2015 Apr 15;136(8):1803-13. doi: 10.1002/ijc.29181. Epub 2014 Sep 15.

31.

Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer.

Lyons TR, Borges VF, Betts CB, Guo Q, Kapoor P, Martinson HA, Jindal S, Schedin P.

J Clin Invest. 2014 Sep;124(9):3901-12. doi: 10.1172/JCI73777. Epub 2014 Aug 18.

32.

Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.

Fornetti J, Martinson HA, Betts CB, Lyons TR, Jindal S, Guo Q, Coussens LM, Borges VF, Schedin P.

J Mammary Gland Biol Neoplasia. 2014 Jul;19(2):213-28. doi: 10.1007/s10911-014-9322-z. Epub 2014 Jun 22. Review.

33.

Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling.

Jindal S, Gao D, Bell P, Albrektsen G, Edgerton SM, Ambrosone CB, Thor AD, Borges VF, Schedin P.

Breast Cancer Res. 2014 Mar 28;16(2):R31. doi: 10.1186/bcr3633.

34.

Physiological COX-2 expression in breast epithelium associates with COX-2 levels in ductal carcinoma in situ and invasive breast cancer in young women.

Fornetti J, Jindal S, Middleton KA, Borges VF, Schedin P.

Am J Pathol. 2014 Apr;184(4):1219-1229. doi: 10.1016/j.ajpath.2013.12.026. Epub 2014 Feb 8.

35.

Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy.

Haricharan S, Dong J, Hein S, Reddy JP, Du Z, Toneff M, Holloway K, Hilsenbeck SG, Huang S, Atkinson R, Woodward W, Jindal S, Borges VF, Gutierrez C, Zhang H, Schedin PJ, Osborne CK, Tweardy DJ, Li Y.

Elife. 2013 Dec 31;2:e00996. doi: 10.7554/eLife.00996.

36.

Rab40b regulates trafficking of MMP2 and MMP9 during invadopodia formation and invasion of breast cancer cells.

Jacob A, Jing J, Lee J, Schedin P, Gilbert SM, Peden AA, Junutula JR, Prekeris R.

J Cell Sci. 2013 Oct 15;126(Pt 20):4647-58. doi: 10.1242/jcs.126573. Epub 2013 Jul 31.

37.

Collagen architecture in pregnancy-induced protection from breast cancer.

Maller O, Hansen KC, Lyons TR, Acerbi I, Weaver VM, Prekeris R, Tan AC, Schedin P.

J Cell Sci. 2013 Sep 15;126(Pt 18):4108-10. doi: 10.1242/jcs.121590. Epub 2013 Jul 10.

38.

Developmental windows of breast cancer risk provide opportunities for targeted chemoprevention.

Martinson HA, Lyons TR, Giles ED, Borges VF, Schedin P.

Exp Cell Res. 2013 Jul 1;319(11):1671-8. doi: 10.1016/j.yexcr.2013.04.018. Epub 2013 May 9. Review.

39.

Genomic signatures of pregnancy-associated breast cancer epithelia and stroma and their regulation by estrogens and progesterone.

Harvell DM, Kim J, O'Brien J, Tan AC, Borges VF, Schedin P, Jacobsen BM, Horwitz KB.

Horm Cancer. 2013 Jun;4(3):140-53. doi: 10.1007/s12672-013-0136-z. Epub 2013 Mar 12.

40.

Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer.

Callihan EB, Gao D, Jindal S, Lyons TR, Manthey E, Edgerton S, Urquhart A, Schedin P, Borges VF.

Breast Cancer Res Treat. 2013 Apr;138(2):549-59. doi: 10.1007/s10549-013-2437-x. Epub 2013 Feb 22.

41.

Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop.

Faupel-Badger JM, Arcaro KF, Balkam JJ, Eliassen AH, Hassiotou F, Lebrilla CB, Michels KB, Palmer JR, Schedin P, Stuebe AM, Watson CJ, Sherman ME.

J Natl Cancer Inst. 2013 Feb 6;105(3):166-74. doi: 10.1093/jnci/djs505. Epub 2012 Dec 21. Review.

42.

Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer.

Giles ED, Wellberg EA, Astling DP, Anderson SM, Thor AD, Jindal S, Tan AC, Schedin PS, Maclean PS.

Cancer Res. 2012 Dec 15;72(24):6490-501. doi: 10.1158/0008-5472.CAN-12-1653. Epub 2012 Dec 7.

43.

Hypothesized role of pregnancy hormones on HER2+ breast tumor development.

Cruz GI, Martínez ME, Natarajan L, Wertheim BC, Gago-Dominguez M, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Schedin P, Komenaka IK, Castelao JE, Carracedo A, Redondo CM, Thompson PA.

Breast Cancer Res Treat. 2013 Jan;137(1):237-46. doi: 10.1007/s10549-012-2313-0. Epub 2012 Nov 8.

44.

Rat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MS/MS analysis.

O'Brien JH, Vanderlinden LA, Schedin PJ, Hansen KC.

J Proteome Res. 2012 Oct 5;11(10):4894-905. doi: 10.1021/pr3003744. Epub 2012 Aug 30.

45.

Alterations in mast cell frequency and relationship to angiogenesis in the rat mammary gland during windows of physiologic tissue remodeling.

Ramirez RA, Lee A, Schedin P, Russell JS, Masso-Welch PA.

Dev Dyn. 2012 May;241(5):890-900. doi: 10.1002/dvdy.23778.

46.

Emerging targets for the prevention of pregnancy-associated breast cancer.

Fornetti J, Martinson H, Borges V, Schedin P.

Cell Cycle. 2012 Feb 15;11(4):639-40. doi: 10.4161/cc.11.4.19358. No abstract available.

47.

Non-steroidal anti-inflammatory drugs target the pro-tumorigenic extracellular matrix of the postpartum mammary gland.

O'Brien J, Hansen K, Barkan D, Green J, Schedin P, O'Brien J, Hansen K, Barkan D, Green J, Schedin P.

Int J Dev Biol. 2011;55(7-9):745-55. doi: 10.1387/ijdb.113379jo.

48.

Macrophages are crucial for epithelial cell death and adipocyte repopulation during mammary gland involution.

O'Brien J, Martinson H, Durand-Rougely C, Schedin P.

Development. 2012 Jan;139(2):269-75. doi: 10.1242/dev.071696. Epub 2011 Nov 30.

49.

Pregnancy-associated breast cancer: an entity needing refinement of the definition.

Borges VF, Schedin PJ.

Cancer. 2012 Jul 1;118(13):3226-8. doi: 10.1002/cncr.26643. Epub 2011 Nov 15. No abstract available.

50.

Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2.

Lyons TR, O'Brien J, Borges VF, Conklin MW, Keely PJ, Eliceiri KW, Marusyk A, Tan AC, Schedin P.

Nat Med. 2011 Aug 7;17(9):1109-15. doi: 10.1038/nm.2416.

Supplemental Content

Loading ...
Support Center